News Articles and Montana BioScience Alliance Newsletters
Endosymbionts are little critters that actually live inside the cells of other organisms. A University of Montana researcher recently earned a $1.5 million grant from the National Science Foundation to study these organisms – especially how they interact with their hosts and the environment – which could help improve health for a huge swath of the world’s population.
When future astronauts heading to Mars sit down to a hearty supper in their spaceship, they may dine on a nutritious, meat-like product made from a microbe that Montana State University scientists discovered in a Yellowstone National Park hot spring.
The four-year grant will enable MSU and its partners from across Montana to deliver quality medical, dental and behavioral health care to kids in rural and underserved areas while providing exceptional educational opportunities for MSU students.
In making the announcement, MSU President Waded Cruzado said “During the pandemic, Dr. Carter helped lead a group of MSU faculty, students and staff in significantly increasing Montana’s COVID-19 testing capacity during the pandemic. He oversaw the MSU research enterprise, the state’s largest, when it set records in expenditures in 2020, 2021 and set it on track to set another record this year.”
Montana State University Billings’ Suzette Nynas, associate professor and department chair for the health and human performance department, was recently inducted into the Montana Athletic Trainers’ Association Hall of Fame.
Are you working to develop an innovative cancer technology? Take a step forward in your commercialization journey through the newly released FY2024 SBIR Contract Solicitation! This funding opportunity aims to provide early-stage funding to small businesses that are developing cancer technologies in areas defined by the National Cancer Institute.
The U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that a confirmatory trial verified clinical benefit.
The PHS 2023-2 omnibus solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications have been released. The first application due date is Tuesday, September 5, 2023.
The panel’s decision moves the U.S. one step closer to making jabs against respiratory syncytial virus available to the public this fall, when the disease typically begins to spread at higher levels.
The biennial report provides a national snapshot of the most pressing current and anticipated talent needs of the nation’s dynamic life science industry. This year’s report distills a set of key themes sourced from 185 executive interviews and nearly 700 survey responses from companies in eighteen states and Puerto Rico, as well as an assessment of nearly 2.8M job postings from life science companies over the last four years.
View the Summer 2023 Newsletter now!
View the Spring 2023 Newsletter now!